(9) In the context of the COVID-19 crisis it has become apparent that it is necessary to extend the scope of Regulation (EU) 2016/369 in order to provide financing to cover urgent needs for medical equipment and materials, such as respiratory ventilators and protective gear, chemical supplies for tests, the costs for the development, production and distribution of medication, other supplies and materials.
(9) COVID-19 kriisi käigus on selgunud, et on vaja laiendada määruse (EL) 2016/369 kohaldamisala, et rahastada kulusid, mis on seotud vajadusega kiiresti soetada meditsiinivahendeid ja -materjale, nagu hingamisaparaadid ja kaitsevahendid ning testimiseks vajalikud kemikaalid, ning töötada välja, toota ja turustada ravimeid ning muid vahendeid ja materjale.